Novel GPC3 Gene Mutation in Simpson-Golabi-Behmel Syndrome with Endocrine Anomalies: A Case Report
, , , e
05 giu 2022
INFORMAZIONI SU QUESTO ARTICOLO
Categoria dell'articolo: Case Report
Pubblicato online: 05 giu 2022
Pagine: 95 - 98
DOI: https://doi.org/10.2478/bjmg-2021-0024
Parole chiave
© 2021 W Bu et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Figure 1

Figure 2

Endocrine evaluation of the patient with the GPC3 c_185delT mutation_
Follicle-stimulating hormone | 3.16 IU/L | 1.50–12.40 IU/L (male) | normal |
Luteinizing hormone | 7.27 IU/L | 1.70–8.60 IU/L (male) | normal |
Prolactin | 46.65 ng/mL | 4.04–15.20 ng/mL | high |
Testosterone | 4.77 ng/mL | 0.03–0.68 ng/mL | high |
Estradiol | <5.00 ng/L | 25.80–60.70 ng/L (male) | low |
Progesterone | 0.221 μg/L | 0.200–1.400 μg/L (male) | normal |
Thyroid-stimulating hormone | 5.370 μIU/mL | 0.270–4.200 μIU/mL (male) | high |
Free triiodothyronine | 4.54 pmol/L | 3.50–7.70 pmol/L | normal |
Free thyroxine | 17.38 pmol/L | 12.00–22.00 pmol/L | normal |
Adrenocortoctropic hormone | 48.19 pg/mL | 5.00–60.00 pg/mL | normal |
Random cortisol | 278.20 nmol/L (8:00 a.m.); |
172.00–497.00 nmol/L (a.m.) |
normal |
Growth hormone | 1.65 ng/mL | 0.12–8.90 ng/mL | normal |